In conclusion, DMRTA2 activates the p53 pathway by binding to HSP90β, inhibiting its ubiquitination and nuclear export of p53, and suppressing the proliferation and invasion of lung cancer cells (Figure 13C). The gene discussed is HSP90AB1; the disease is lung cancer.